Rhumbline Advisers Pacific Biosciences Of California, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 418,622 shares of PACB stock, worth $602,815. This represents 0.0% of its overall portfolio holdings.
Number of Shares
418,622
Previous 412,900
1.39%
Holding current value
$602,815
Previous $701,000
9.27%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding PACB
# of Institutions
255Shares Held
229MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36MShares$51.9 Million0.58% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$34 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$33.7 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$29.2 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$25.4 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $324M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...